Eversept Partners, LP Viatris Inc Transaction History
Eversept Partners, LP
- $1.33 Billion
- Q1 2024
A detailed history of Eversept Partners, LP transactions in Viatris Inc stock. As of the latest transaction made, Eversept Partners, LP holds 1,316,469 shares of VTRS stock, worth $14 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
1,316,469Holding current value
$14 Million% of portfolio
1.18%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,096Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.5 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$992 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$667 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$615 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$611 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...